Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome Therapeutics price target raised to $200 from $145 at SunTrust AXSM
12:45pm, Tuesday, 28'th Apr 2020
Axsome Therapeutics price target raised to $200 from $145 at SunTrust SunTrust AXSM
Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Alphatec Holdings (ATEC)
11:18am, Tuesday, 28'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics (AXSM) and Alphatec Holdings (ATEC)
6 Stock Charts To Watch: AUDC, DVAX, INMD, QTNT, RDHL, VKTX
12:00am, Tuesday, 28'th Apr 2020
Stocks Analysis by Harry Boxer covering: Alphabet Inc Class A, Bed Bath & Beyond Inc, Crude Oil WTI Futures, AudioCodes Ltd. Read Harry Boxer's latest article on Investing.com
Tesla, Big Lots rise; Embraer, Regeneron fall
08:22pm, Monday, 27'th Apr 2020
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday: Embraer SA, down 41 cents to $5.41. Boeing pulled out of a deal to buy the Brazilian jet maker's commercial aviation busi
Tesla, Big Lots rise; Embraer, Regeneron fall
08:22pm, Monday, 27'th Apr 2020
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:
Embraer SA, down 41 cents to $5.41.
Boeing pulled out of a deal to buy the Brazilian jet maker's commercial aviation busi
Fly Intel: Pre-market Movers GM;ERJ;BA;AXSM;FCAU;HARP;CHKP;LXRX;VSTO;CNXM;DO;W;CLVS
01:37pm, Monday, 27'th Apr 2020
Fly Intel: Pre-market Movers GM ERJ BA AXSM FCAU HARP CHKP LXRX VSTO CNXM DO W CLVS
AMRN, EPR among top gainers
01:21pm, Monday, 27'th Apr 2020
Axsome Therapeutics (NASDAQ:AXSM) +44% as Axsome's lead candidate successful in Alzheimer's study.Avadel Pharmaceuticals plc (NASDAQ:AVDL) +34% on positive data on lead drug.Yield10 Bioscience (NA
Avadel up 30% premarket on positive data on lead drug
12:01pm, Monday, 27'th Apr 2020
Avadel Pharmaceuticals (NASDAQ:AVDL) jumps 30% premarket on average volume in reaction to positive results from a Phase 3 clinical trial, REST-ON, evaluating lead candidate FT218, a once-nightly for
Statistically significant improvement in Alzheimer’s disease agitation, as measured by the CMAI total score compared to placebo (p=0.010, primary endpoint) Demonstrated rapid.
Statistically significant improvement in Alzheimer’s disease agitation, as measured by the CMAI total score compared to placebo (p=0.010, primary endpoint)...
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald AXSM
07:35am, Monday, 27'th Apr 2020
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald Cantor Fitzgerald AXSM
Axsome Therapeutics price target raised to $186 from $165 at Ladenburg AXSM
07:15am, Monday, 27'th Apr 2020
Axsome Therapeutics price target raised to $186 from $165 at Ladenburg Ladenburg AXSM
Why Axsome Is Touching The $100 Level For The First Time In Months
12:00am, Monday, 27'th Apr 2020
Axsome Therapeutics Inc (NASDAQ: AXSM), which was a high-flier for most of 2019, has come off the all-time highs reached late last year thanks to the COVID-19 pandemic and a...
Axsome Therapeutics (AXSM) - Investment Analysts' Recent Ratings Updates
05:22am, Friday, 17'th Apr 2020
Axsome Therapeutics (NASDAQ: AXSM) has recently received a number of price target changes and ratings updates: 4/14/2020 – Axsome Therapeutics is now covered by analysts at Cowen Inc. They set an �
2 Top Small-Cap Stocks to Buy Right Now
12:09pm, Wednesday, 15'th Apr 2020
These development-stage drug companies are well positioned for success, even amid the current market uncertainty.
